James F. Simpson

1.1k total citations
17 papers, 845 citations indexed

About

James F. Simpson is a scholar working on Molecular Biology, Physiology and Neurology. According to data from OpenAlex, James F. Simpson has authored 17 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Physiology and 4 papers in Neurology. Recurrent topics in James F. Simpson's work include RNA Research and Splicing (6 papers), Alzheimer's disease research and treatments (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). James F. Simpson is often cited by papers focused on RNA Research and Splicing (6 papers), Alzheimer's disease research and treatments (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). James F. Simpson collaborates with scholars based in United States, Czechia and Bulgaria. James F. Simpson's co-authors include Steven Estus, Ralph R. Meyer, William Lewis, David W. Fardo, Ishita Parikh, Manasi Malik, Bernard R. Wilfred, Peter T. Nelson, Brian M. Davis and Kathryn M. Albers and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Circulation Research.

In The Last Decade

James F. Simpson

16 papers receiving 833 citations

Peers

James F. Simpson

PHYSI

CMN

NEURO

Luis B. Tovar‐y‐Romo Mexico

Ted M. Dawson United States

Damodaran Narayanan United States

Nael A. Al‐Abdulla United States

M Wender Poland

Lena Bezman United States

Mariana G. Tarragó United States

Anandakumar Shunmugavel United States

J J Hauw France

Elke Maes Germany

Luis B. Tovar‐y‐Romo Mexico

James F. Simpson

95 ×0.3

PHYSI

519 ×1.5

268 ×1.8

CMN

238 ×1.7

NEURO

89 ×1.0

Citations per year, relative to James F. Simpson James F. Simpson (= 1×) peers Luis B. Tovar‐y‐Romo

Countries citing papers authored by James F. Simpson

Since Specialization

Citations

This map shows the geographic impact of James F. Simpson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James F. Simpson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James F. Simpson more than expected).

Fields of papers citing papers by James F. Simpson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James F. Simpson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James F. Simpson. The network helps show where James F. Simpson may publish in the future.

Co-authorship network of co-authors of James F. Simpson

This figure shows the co-authorship network connecting the top 25 collaborators of James F. Simpson. A scholar is included among the top collaborators of James F. Simpson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James F. Simpson. James F. Simpson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Turner, A., et al.. (2023). Skipping of FCER1G Exon 2 Is Common in Human Brain But Not Associated with the Alzheimer’s Disease Genetic Risk Factor rs2070902. Journal of Alzheimer s Disease Reports. 7(1). 1313–1322.

Turner, A., et al.. (2022). An Alternatively Spliced TREM2 Isoform Lacking the Ligand Binding Domain is Expressed in Human Brain. Journal of Alzheimer s Disease. 87(4). 1647–1657. 13 indexed citations

Turner, A., et al.. (2022). Identification and Quantitation of Novel ABI3 Isoforms Relative to Alzheimer’s Disease Genetics and Neuropathology. Genes. 13(9). 1607–1607. 5 indexed citations

Katsumata, Yuriko, et al.. (2021). Analysis of Genetic Variants Associated with Levels of Immune Modulating Proteins for Impact on Alzheimer’s Disease Risk Reveal a Potential Role for SIGLEC14. Genes. 12(7). 1008–1008. 9 indexed citations

Vasquez, Jared B., et al.. (2017). Alzheimer’s Disease Genetics and ABCA7 Splicing. Journal of Alzheimer s Disease. 59(2). 633–641. 12 indexed citations

Malik, Manasi, James F. Simpson, Ishita Parikh, et al.. (2013). CD33 Alzheimer's Risk-Altering Polymorphism, CD33 Expression, and Exon 2 Splicing. Journal of Neuroscience. 33(33). 13320–13325. 203 indexed citations

Ling, I‐Fang, et al.. (2012). Genetics of Clusterin Isoform Expression and Alzheimer's Disease Risk. PLoS ONE. 7(4). e33923–e33923. 57 indexed citations

Ling, I‐Fang, et al.. (2010). Expression and regulation of a low‐density lipoprotein receptor exon 12 splice variant. Journal of Neurochemistry. 115(3). 614–624. 7 indexed citations

Ling, I‐Fang, James F. Simpson, Jennifer L. Furman, et al.. (2009). Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain. Molecular Neurodegeneration. 4(1). 46–46. 47 indexed citations

10.

Zou, Fangdong, Haiyan Zhu, James F. Simpson, et al.. (2007). Sex-dependent association of a common low-density lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer's disease. Human Molecular Genetics. 17(7). 929–935. 49 indexed citations

11.

Zhu, Haiyan, H. Michael Tucker, James F. Simpson, et al.. (2007). A common polymorphism decreases low-density lipoprotein receptor exon 12 splicing efficiency and associates with increased cholesterol. Human Molecular Genetics. 16(14). 1765–1772. 72 indexed citations

12.

McGonigle, Kathryn F., et al.. (2006). Uterine effects of tamoxifen: a prospective study. International Journal of Gynecological Cancer. 16(2). 814–820. 1 indexed citations

13.

Zwick, Melissa, Brian M. Davis, C. Jeffrey Woodbury, et al.. (2002). Glial Cell Line-Derived Neurotrophic Factor is a Survival Factor for Isolectin B4-Positive, but not Vanilloid Receptor 1-Positive, Neurons in the Mouse. Journal of Neuroscience. 22(10). 4057–4065. 184 indexed citations

14.

Page, David L., et al.. (2000). No elevation of long-term breast cancer risk in women with fibroadenoma containing atypia. Laboratory Investigation. 80(3). 18. 1 indexed citations

15.

Lewis, William, Ralph R. Meyer, James F. Simpson, Joseph M. Colacino, & Fred W. Perrino. (1994). Mammalian DNA Polymerases .alpha., .beta., .gamma., .delta., and .epsilon. Incorporate Fialuridine (FIAU) Monophosphate into DNA and Are Inhibited Competitively by FIAU Triphosphate. Biochemistry. 33(48). 14620–14624. 60 indexed citations

16.

Lewis, William, James F. Simpson, & Ralph R. Meyer. (1994). Cardiac mitochondrial DNA polymerase-gamma is inhibited competitively and noncompetitively by phosphorylated zidovudine.. Circulation Research. 74(2). 344–348. 124 indexed citations

17.

Simpson, James F.. (1991). Journal of the Reform Year.. The Executive educator. 13(12). 29–31. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact